发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| England | 519 |
| USA | 422 |
| CHINA MAINLAND | 147 |
| GERMANY (FED REP GER) | 147 |
| Scotland | 135 |
| Italy | 128 |
| France | 122 |
| Australia | 108 |
| Japan | 103 |
| Canada | 86 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| UNIVERSITY OF LONDON | 202 |
| UNIVERSITY OF OXFORD | 100 |
| HARVARD UNIVERSITY | 88 |
| ROYAL MARSDEN NHS FOUNDATION TRUST | 78 |
| UNIVERSITY OF CAMBRIDGE | 71 |
| UNIVERSITY OF TEXAS SYSTEM | 69 |
| UNICANCER | 64 |
| CANCER RESEARCH UK | 57 |
| UNIVERSITY OF MANCHESTER | 57 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC... | 56 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Mechanisms of resistance to immune checkpoint inhibitors | 159 |
| The fraction of cancer attributable to modifiable risk f... | 69 |
| Cytokines in clinical cancer immunotherapy | 69 |
| Resistance mechanisms to osimertinib in EGFR-mutated non... | 63 |
| Efficacy and safety of pembrolizumab in recurrent/metast... | 62 |
| Immunosuppression mediated by myeloid-derived suppressor... | 58 |
| Derazantinib (ARQ 087) in advanced or inoperable FGFR2 g... | 50 |
| The clinical role of the TME in solid cancer | 43 |
| Anlotinib as a third-line therapy in patients with refra... | 37 |
| PD-L1 mRNA expression in plasma-derived exosomes is asso... | 36 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| CANCERS | 1280 |
| SCI REP-UK | 808 |
| INT J MOL SCI | 786 |
| FRONT ONCOL | 594 |
| BMC CANCER | 565 |
| ONCOL LETT | 472 |
| PLOS ONE | 411 |
| CANCER MANAG RES | 365 |
| CELLS-BASEL | 357 |
| J CELL PHYSIOL | 343 |